0001144204-17-035031.txt : 20170629 0001144204-17-035031.hdr.sgml : 20170629 20170629210114 ACCESSION NUMBER: 0001144204-17-035031 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170627 FILED AS OF DATE: 20170629 DATE AS OF CHANGE: 20170629 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INTERCEPT PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001270073 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 223868459 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 450 W. 15TH STREET STREET 2: SUITE 505 CITY: NEW YORK STATE: NY ZIP: 10011 BUSINESS PHONE: 646-747-1000 MAIL ADDRESS: STREET 1: 450 W. 15TH STREET STREET 2: SUITE 505 CITY: New York STATE: NY ZIP: 10011 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Fundaro Paolo CENTRAL INDEX KEY: 0001559537 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35668 FILM NUMBER: 17940007 MAIL ADDRESS: STREET 1: C/O GENEXTRA S.P.A., STREET 2: VIA G. DE GRASSI, 11 CITY: MILAN STATE: L6 ZIP: 20123 4 1 v470072_form4.xml FORM 4 X0306 4 2017-06-27 0 0001270073 INTERCEPT PHARMACEUTICALS INC ICPT 0001559537 Fundaro Paolo C/O INTERCEPT PHARMACEUTICALS, INC. 10 HUDSON YARDS, FLOOR 37 NEW YORK NY 10001 1 0 0 0 Common Stock 2017-06-27 4 A 0 1423 0 A 11498 D Option to Purchase Common Stock 122.01 2017-06-27 4 A 0 2036 0 A 2027-06-27 Common Stock 2036 2036 D The 1,423 shares of restricted stock and the shares of 2,036 shares of common stock underlying the option will each fully vest on the one-year anniversary of the date of grant (the "Anniversary Date"), subject to the terms and conditions of the award and the Intercept Pharmaceuticals, Inc. 2012 Equity Incentive Plan (the "2012 Plan"); provided, however, if the date of the next subsequent annual meeting of stockholders (starting from the 2018 annual meeting) is held prior to the Anniversary Date in that year, the annual vesting for such year shall occur on the day immediately preceding the date of the annual meeting in such year. /s/ Bryan Yoon, as attorney-in-fact 2017-06-29